학술논문
Daratumumab activity in relapsed or primary refractory systemic AL amyloidosis and Fcγ receptor 3A V158F polymorphisms.
Document Type
Letter
Author
Source
Subject
*CARDIAC amyloidosis
*AMYLOIDOSIS
*
Language
ISSN
1350-6129